2012Zhongguo shiyan fangjixue zazhiRequires access

Effects of Triptolide on Proliferation and Apoptosis of Human Hepatocytes

DU Xing-dong

Open publisher page 1 citations

Abstract

Objective:To study the effects of triptolide on proliferation and apoptosis of human hepatocytes(L-02 cells),providing experimental basis for the clinical application of triptolide in treatment of liver diseases and the prevention of its liver toxicity.Method: Culture L-02 cells in vitro and treat the L-02 cells with 10,30,50 nmol·L-1 triptolide respectively for 48 h.Detect the cellular growth and proliferation using trypan blue staining and Brdu incorporation,detect cell cycle distribution using PI staining,detect the percentage of cellular apoptosis using AV/PI double staining,detect the expression levels of p21 and p53 using western blot analysis.Result: Compared with the control,after treated with 10,30,50 nmol · L-1 triptolide,the cell number was reduced from(2.72±1.14)×105 cells/mL to(1.95±0.38)×105,(1.44±0.44)×105,(6.97±0.47)×104 cells/mL respectively;the percentage of Brdu positive cells was reduced from(7.67±0.51)% to(5.67±0.29)%,(4.05±0.14)%,(2.51±0.15)% respectively;the percentage of cells arrested in G1 stage was increased from 65.39% to 68.47%,71.19%,83.98% respectively;the percentage of apoptotic cells was increased from(20.54±1.44)% to(28.02±0.93)%,(36.79±0.49)%,(43.35±1.12)% respectively;the expression level of p21 and p53 protein were both up-regulated,and showed a dose-effect relationship.Conclusion: Triptolide could inhibit L-02 cells proliferation through up-regulation of p21 expression thus arresting cells in G1 stage,and induce cellular apoptosis through up-regulation of p53 expression in L-02 cells.

About this research paper

What this paper is about

Objective:To study the effects of triptolide on proliferation and apoptosis of human hepatocytes(L-02 cells),providing experimental basis for the clinical application of triptolide in treatment of liver diseases and the prevention of its liver toxicity.Method: Culture L-02 cells in vitro and treat the L-02 cells with 10,30,50 nmol·L-1 triptolide respectively for 48 h.Detect the cellular growth and proliferation using trypan blue staining and Brdu incorporation,detect cell cycle distribution using PI staining,detect the percentage of cellular apoptosis using AV/PI double staining,detect the expression levels of p21 and p53 using western blot analysis.Result: Compared with the control,after treated with 10,30,50 nmol · L-1 triptolide,the cell number was reduced from(2.72±1.14)×105 cells/mL to(1.95±0.38)×105,(1.44±0.44)×105,(6.97±0.47)×104 cells/mL respectively;the percentage of Brdu positive cells was reduced from(7.67±0.51)% to(5.67±0.29)%,(4.05±0.14)%,(2.51±0.15)% respectively;the percentage of cells arrested in G1 stage was increased from 65.39% to 68.47%,71.19%,83.98% respectively;the percentage of apoptotic cells was increased from(20.54±1.44)% to(28.02±0.93)%,(36.79±0.49)%,(43.35±1.12)% respectively;the expression level of p21 and p53 protein were both up-regulated,and showed a dose-effect relationship.Conclusion: Triptolide could inhibit L-02 cells proliferation through up-regulation of p21 expression thus arresting cells in G1 stage,and induce cellular apoptosis through up-regulation of p53 expression in L-02 cells.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the effects of triptolide on proliferation and apoptosis of human hepatocytes(L-02 cells),providing experimental basis for the clinical application of triptolide in treatment of liver diseases and the prevention of its liver toxicity.Method: Culture L-02 cells in vitro and treat the L-02 cells with 10,30,50 nmol·L-1 triptolide respectively for 48 h.Detect the cellular growth and proliferation using trypan blue staining and Brdu incorporation,detect cell cycle distribution using PI staining,detect the percentage of cellular apoptosis using AV/PI double staining,detect the expression levels of p21 and p53 using western blot analysis.Result: Compared with the control,after treated with 10,30,50 nmol · L-1 triptolide,the cell number was reduced from(2.72±1.14)×105 cells/mL to(1.95±0.38)×105,(1.44±0.44)×105,(6.97±0.47)×104 cells/mL respectively;the percentage of Brdu positive cells was reduced from(7.67±0.51)% to(5.67±0.29)%,(4.05±0.14)%,(2.51±0.15)% respectively;the percentage of cells arrested in G1 stage was increased from 65.39% to 68.47%,71.19%,83.98% respectively;the percentage of apoptotic cells was increased from(20.54±1.44)% to(28.02±0.93)%,(36.79±0.49)%,(43.35±1.12)% respectively;the expression level of p21 and p53 protein were both up-regulated,and showed a dose-effect relationship.Conclusion: Triptolide could inhibit L-02 cells proliferation through up-regulation of p21 expression thus arresting cells in G1 stage,and induce cellular apoptosis through up-regulation of p53 expression in L-02 cells.

Key concepts: Triptolide, Apoptosis, Cell growth, Staining, Cell counting, Molecular biology, Cell cycle, Pi

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Triptolide on Proliferation and Apoptosis of Human Hepatocytes — Research Paper | ScholarLens